Breast Cancer Therapy
Researchers from College of Medicine, Department of Health Sciences Research publish new studies and findings in the area of breast cancer therapy
Published in Women's Health Weekly, June 14th, 2007
A new study, "Pilot study of the impact of letrozole vs. placebo on breast density in women completing 5 years of tamoxifen," is now available. According to recent research from the United States, "Breast density, a strong risk factor for breast cancer, is reduced by the anti-estrogen, tamoxifen (TAM). We examined whether aromatase inhibitor (AI) therapy results in further reductions in breast density among women completing 5 years of TAM."
"Among a sample of women with early-onset breast cancer who were randomized to letrozole (LET)(n=56) or placebo (PLAC)(n=48) after 5 years of TAM, we examine the change in percent density at 9-15 months as well as a per-year change...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
IMRT Allows Higher Radiation Therapy Dose for Breast Cancer - Breast Cancer
Increasing, Consolidating Radiation Dose Can Shorten Treatment Time for Women Who Choose Breast Sparing Treatment - Breast Cancer
Intake of vitamin D and calcium associated with lower risk of breast cancer before menopause - Breast Cancer
MRI detects cancers missed by mammography in breast cancer patients - Breast Cancer
Researchers Home In On Possible New Breast Cancer Gene - HIV/AIDS Co-Infection
Rapid syphilis testing in Haiti will prevent congenital disease and stillbirths - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
